Intellectual Property India Publishes Patent Application for Novel Antibodies That Bind To Cd3 And Lilrb4, And Uses Thereof

MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617082890 A) filed by Antengene Biologics Limited on July 06, 2026, for Novel Antibodies That Bind To Cd3 And Lilrb4, And Uses Thereof.

Inventors include Sun, Ao; Gao, Mengshi; Guo, Rong; Hu, Zaoshun; Liu, Huiling; Chen, Peng; Yuwen, Hui; Hou, Bing; Shan, Bo; and Mei, Jay.

The application for the patent was published on August 14, 2026, under issue no. 33/2026.

Abstract: Provided herein are multi-specific, especially bispecific or tri-specific, antibodies or antigen-binding fragments thereof that bind to CD3 and LILRB4, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same and the uses thereof.

Disclaimer: Curated by HT Syndication.